Farber Disease Natural History Study

Clinical trial NCT03233841 · COMPLETED

Trial details

NCT number: NCT03233841
Sponsor: Sumitomo Pharma Switzerland GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Farber Disease Farber's Disease Farber Lipogranulomatosis Acid Ceramidase Deficiency Ceramidase Deficiency N-Laurylsphingosine Deacylase Deficiency ASAH1 Mutation

Start date: 2017-11-22
Primary completion: 2019-10-12
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.